• Username (E-mail)
  • Password
Dow 20,761 -0.2%  EStoxx50 3,304 -0.9%  Nikkei 19,284 -0.5%  EUR 1.0568 -0.1% 
Nasdaq 5,826 -0.2%  FTSE100 7,244 -0.4%  Yen 112.1080 -0.5%  Oil 56.0 -0.8% 
S&P500 2,359 -0.2%  DAX 11,804 -1.2%  GBP 1.2462 -0.7%  Gold 1,257 0.6% 

Alexion Pharmaceuticals share [Symbol: ALXN / ISIN: US0153511094]

Realtimequote Alexion Pharmaceuticals Inc. in USD

Exchange Market
131.43
Last
47,654
Volume
Time 02:25 PM
02/24/2017 02:25:00 PM UTC-0500
activate push

Stock Price Alexion Pharmaceuticals Inc. in USD

Activate push
131.16 USD 0.72 USD 0.55 %
Trade Time 2:10 PM Trade Date 2/24/2017
Daily High 132.46 Open 131.37
Daily Low 130.00 Prev. Close 130.44
52-week High 161.86 Volume (Qty.) 321,750
52-week Low 109.13 Market Cap (USD) 29.52 B
52-week Perf.
Exchange

Analyst Opinions for Alexion Pharmaceuticals Inc.

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
10/25/12
Alexion Pharmaceuticals UBS AG
07/27/12
Alexion Pharmaceuticals Stifel, Nicolaus & Co., Inc.
07/26/12
Alexion Pharmaceuticals UBS AG
04/26/12
Alexion Pharmaceuticals Jefferies & Company Inc.
02/23/12
Alexion Pharmaceuticals UBS AG

Moody's Rating for Alexion Pharmaceuticals Inc.

Investment Grade (High Grade)
Investment Grade (Medium Grade)
Speculative Grade
Rating
Rating Update
Date of Rating
Rating Office -

Profile Alexion Pharmaceuticals Inc.

Company Profile
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Its products include soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in New Haven, CT.
pagehit

Add or Edit Instrument

Alexion Pharmaceuticals Chart - 1 Year - NAS
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: NAS
  • Chart Options

Estimates for Alexion Pharmaceuticals

2016 2017e 2018e
Dividend - - -
Dividend Yield in % - - -
P/E Ratio 26.89 23.59 18.52
EPS 4.62 5.29 6.74

Alexion Pharmaceuticals Key Figures

Market Cap (USD) 29.52 B
Free Float in % 99.46
Number of Shares (Mio.) 224.61
Cash Flow per Share 2.83
Book Value per Share 36.72
60-Days Volatility 47.7
P/B Ratio 3.38

Base Data Alexion Pharmaceuticals

Symbol ALXN
ISIN US0153511094
Indices BX Swiss - USA, NASDAQ Comp., S&P 500, NASDAQ 100

About the Company Alexion Pharmaceuticals

Country USA

Alexion Pharmaceuticals Historical Prices

02/22/2017
02/22/2017 06:00:00 PM UTC-0500
130.44 509,273
02/21/2017
02/21/2017 06:00:00 PM UTC-0500
130.83 474,022
02/20/2017
02/20/2017 06:00:00 PM UTC-0500
129.89 986,387
02/16/2017
02/16/2017 06:00:00 PM UTC-0500
128.82 1,053,381
02/15/2017
02/15/2017 06:00:00 PM UTC-0500
130.39 1,665,916

Alexion Pharmaceuticals Peer Group

Abbott Laboratories 45.51
0.2%
Alexion Pharmaceuticals 131.16
0.6%
AstraZeneca 46.16
0.3%
Bayer 104.55
-0.4%
GlaxoSmithKline 16.42
0.6%
Johnson & Johnson 122.10
0.3%
Merck 65.73
-0.2%
Novartis 77.45
-0.3%
Pfizer 34.08
0.1%
Roche 248.10
-0.3%

Similar shares with higher 1-year perf.